Today we interview with Dan Lunz, co-founder and CEO of Previse, an innovative medical solutions company specializing in cancer prevention and early detection. Lunz talks about his journey from being a Marine to leading a pioneering medical company. He discusses the scientific technology behind Previse, which started out as research for predicting esophageal cancer in patients with Barrett's esophagus. Lunz also shares about the company's current fundraising activities, commercialization plans, compliance with regulatory standards, and long-term goals for cancer detection. He hints at exciting future announcements about Previse's new developments, tests, and pipeline technologies. https://previsedx.com/  https://www.linkedin.com/in/danlunz/  00:43 The Journey of Previse: Aiming for Early Cancer Detection 05:24 The Previse Technology: A New Approach to Cancer Detection 07:45 The Impact of Previse in the Medical Field 10:13 Fundraising and the Future of Previse 14:51 Navigating the Regulatory Landscape 18:02 Balancing Innovation and Compliance 21:15 Long-term Goals and Future Developments Qualio website: https://www.qualio.com/ Previous episodes: https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show: https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez